Below, a list of constituents for IDNA (iShares Genomics Immunology and Healthcare ETF) is shown. In total, IDNA consists of 68 securities.
Note: The data shown here is as of date Mar 31, 2026 (the latest that can be sourced directly from the fund provider).
Click here to go back to the full list of ETFs.
| Ticker | Name | Sector | Asset Class | Market Value | Weight (%) |
| RVMD | REVOLUTION MEDICINES INC | Health Care | Equity | 11530417.75 | 6.97 |
| MRNA | MODERNA INC | Health Care | Equity | 10706526.39 | 6.47 |
| IPN | IPSEN SA | Health Care | Equity | 8701983.78 | 5.26 |
| 4502 | TAKEDA PHARMACEUTICAL LTD | Health Care | Equity | 7173039.03 | 4.34 |
| BAYN | BAYER AG | Health Care | Equity | 7093981.89 | 4.29 |
| MRK | MERCK & CO INC | Health Care | Equity | 6922163.36 | 4.19 |
| EXEL | EXELIXIS INC | Health Care | Equity | 6673214.9 | 4.04 |
| ROP | ROCHE PS PAR AG | Health Care | Equity | 6497086.96 | 3.93 |
| GSK | GLAXOSMITHKLINE | Health Care | Equity | 6437779.86 | 3.89 |
| TWST | TWIST BIOSCIENCE CORP | Health Care | Equity | 6187310.08 | 3.74 |
| REGN | REGENERON PHARMACEUTICALS INC | Health Care | Equity | 6101525.1 | 3.69 |
| BNTX | BIONTECH SE ADR | Health Care | Equity | 6015954.78 | 3.64 |
| INCY | INCYTE CORP | Health Care | Equity | 5920206.35 | 3.58 |
| VRTX | VERTEX PHARMACEUTICALS INC | Health Care | Equity | 5706989.25 | 3.45 |
| SAN | SANOFI SA | Health Care | Equity | 5387355.18 | 3.26 |
| GMAB | GENMAB | Health Care | Equity | 5340027.37 | 3.23 |
| IBRX | IMMUNITYBIO INC | Health Care | Equity | 4943697.2 | 2.99 |
| IDYA | IDEAYA BIOSCIENCES INC | Health Care | Equity | 4294733.16 | 2.6 |
| CAI | CARIS LIFE SCIENCES INC | Health Care | Equity | 3934486.23 | 2.38 |
| RCUS | ARCUS BIOSCIENCES INC | Health Care | Equity | 3473574.0 | 2.1 |
| 4528 | ONO PHARMACEUTICAL LTD | Health Care | Equity | 3165849.97 | 1.91 |
| CRSP | CRISPR THERAPEUTICS AG | Health Care | Equity | 3047906.88 | 1.84 |
| NVAX | NOVAVAX INC | Health Care | Equity | 2475832.32 | 1.5 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | Health Care | Equity | 2428985.56 | 1.47 |
| NUVB | NUVATION BIO INC CLASS A | Health Care | Equity | 2150275.68 | 1.3 |
| ABCL | ABCELLERA BIOLOGICS INC | Health Care | Equity | 2072896.56 | 1.25 |
| 2595 | GENFLEET THERAPEUTICS (SHANGHAI) I | Health Care | Equity | 1796080.81 | 1.09 |
| VIR | VIR BIOTECHNOLOGY INC | Health Care | Equity | 1724315.88 | 1.04 |
| CRVS | CORVUS PHARMACEUTICALS INC | Health Care | Equity | 1578495.6 | 0.95 |
| KURA | KURA ONCOLOGY INC | Health Care | Equity | 1438493.2 | 0.87 |
| JANX | JANUX THERAPEUTICS INC | Health Care | Equity | 1402686.66 | 0.85 |
| 6887 | SUNSHINE LAKE PHARMA LTD CLASS H | Health Care | Equity | 1062135.21 | 0.64 |
| CTMX | CYTOMX THERAPEUTICS INC | Health Care | Equity | 941801.07 | 0.57 |
| NTLA | INTELLIA THERAPEUTICS INC | Health Care | Equity | 922313.05 | 0.56 |
| 174900 | ABCLON INC | Health Care | Equity | 855544.37 | 0.52 |
| XTSLA | BLK CSH FND TREASURY SL AGENCY | Cash and/or Derivatives | Money Market | 853930.84 | 0.52 |
| RIGL | RIGEL PHARMACEUTICALS INC | Health Care | Equity | 840451.71 | 0.51 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA | Health Care | Equity | 825971.04 | 0.5 |
| DSGN | DESIGN THERAPEUTICS INC | Health Care | Equity | 811322.55 | 0.49 |
| 2696 | SHANGHAI HENLIUS BIOTECH INC H | Health Care | Equity | 805237.83 | 0.49 |
| OCGN | OCUGEN INC | Health Care | Equity | 798343.95 | 0.48 |
| DNA | GINKGO BIOWORKS HOLDINGS INC CLASS | Health Care | Equity | 758953.44 | 0.46 |
| VLA | VALNEVA | Health Care | Equity | 703779.89 | 0.43 |
| VSTM | VERASTEM INC | Health Care | Equity | 698818.76 | 0.42 |
| ALVO | ALVOTECH SA | Health Care | Equity | 672513.03 | 0.41 |
| PSNL | PERSONALIS INC | Health Care | Equity | 574646.9 | 0.35 |
| XNCR | XENCOR INC | Health Care | Equity | 528778.44 | 0.32 |
| EUR | EUR CASH | Cash and/or Derivatives | Cash | 338472.21 | 0.2 |
| 2591 | GUANGZHOU INNOGEN PHARMACEUTICAL G | Health Care | Equity | 204186.44 | 0.12 |
| PRME | PRIME MEDICINE INC | Health Care | Equity | 193844.86 | 0.12 |
| MREO | MEREO BIOPHARMA GROUP ADR REPRESEN | Health Care | Equity | 55181.73 | 0.03 |
| HBCFT | CASH COLLATERAL USD HBCFT | Cash and/or Derivatives | Cash Collateral and Margins | 52000.0 | 0.03 |
| nan | ARCELLX INC Prvt | Health Care | Equity | 5114.13 | 0.0 |
| JPY | JPY/USD | Cash and/or Derivatives | FX | 1388.22 | 0.0 |
| KRW | KRW CASH | Cash and/or Derivatives | Cash | 423.55 | 0.0 |
| TWD | TWD CASH | Cash and/or Derivatives | Cash | 166.19 | 0.0 |
| CHF | CHF CASH | Cash and/or Derivatives | Cash | 167.55 | 0.0 |
| HKD | HKD CASH | Cash and/or Derivatives | Cash | 168.11 | 0.0 |
| DKK | DKK CASH | Cash and/or Derivatives | Cash | 168.83 | 0.0 |
| GBP | GBP CASH | Cash and/or Derivatives | Cash | 169.88 | 0.0 |
| EUR | EUR/USD | Cash and/or Derivatives | FX | -0.42 | 0.0 |
| nan | OMNIAB INC $12.50 VESTING Prvt | Health Care | Equity | 0.19 | 0.0 |
| nan | OMNIAB INC $15.00 VESTING Prvt | Health Care | Equity | 0.19 | 0.0 |
| IXCM6 | E-MINI HEALTH CARE SECTOR JUN 26 | Cash and/or Derivatives | Futures | 0.0 | 0.0 |
| JPY | JPY/USD | Cash and/or Derivatives | FX | -57.87 | 0.0 |
| USD | USD CASH | Cash and/or Derivatives | Cash | -79916.31 | -0.05 |
| JPY | JPY CASH | Cash and/or Derivatives | Cash | -376780.24 | -0.23 |
| The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. | nan | nan | nan | nan | nan |
Alphalerts is a Chapati Systems GmbH Service.
Made with Chai in Germany.
